M. Nash

Amyloid-β ¹¹ C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 152 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials

Mack Roach, Vivian Weinberg, M. Nash et al. · The Journal of Urology · 2006 · 45 citations

Medicine, Oncology, Urology +9

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab

Enchi Liu, Dai Wang, Reisa A. Sperling et al. · Neurology · 2018 · 41 citations · Full text

Medicine, Neurology, Neuroscience +17

Increasing FFD: An effective dose-reducing tool for lateral lumbar spine investigations

Patrick Brennan, M. Nash · Radiography · 1998 · 37 citations

Medicine, Radiology, Biomedical Imaging +8

Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis

L.R. Caley, Heledd Jarosz-Griffiths, Lesley Smith et al. · Journal of Cystic Fibrosis · 2023 · 37 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +16